Iodine-123 labelled Z-(R,R)-IQNP: A potential radioligand for visualization of M1 and M2 muscarinic acetylcholine receptors in Alzheimer's disease

European Journal of Nuclear Medicine

Volumn 26, Issue 11, 1999, Pages 1482-1485

  Bergström, Kim A ^a,b   Halldin, Christer ^a   Savonen, Aki ^c   Okubo, Yoshiro ^a   Hiltunen, Jukka ^c   Nobuhara, Kenji ^a   Swahn, Carl Gunner ^a   Karlsson, Per ^a   McPherson, Dan ^d   Knapp Jr , Furn F ^d   Larsson, Stig ^a   Schnell, Per Olof ^a   Farde, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c MAP Medical Technologies Oy   (Finland)

^d Clin Physiol and Nuclear Medicine ^*

Author keywords

Brain; Muscarinic acetylcholine receptors; Single photon emission tomography; Z (R,R) IQNP

Indexed keywords

3 QUINUCLIDINYL 4 IODOBENZILATE; IODINE 123; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; RADIOPHARMACEUTICAL AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN TOMOGRAPHY; CEREBELLUM; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG HYDROLYSIS; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONKEY; NEOCORTEX; NONHUMAN; PHOTON EMISSION TOMOGRAPHY; THALAMUS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; IODINE RADIOISOTOPES; LIGANDS; MACACA FASCICULARIS; MALE; MUSCARINIC ANTAGONISTS; QUINUCLIDINES; RECEPTORS, MUSCARINIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032720281     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050482     Document Type: Article

References (11)

1. Reinikainen KJ, Riekkinen PJ, Halonen T, Laakso M. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci 1987; 41: 453-461.
2. Boundy, KL, Barnden LR, Rowe CC, et al. Human dosimetry and biodistribution of iodine-123 iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors. J Nucl Med 1995; 36: 1332-1338.
3. Eckelman WC, Reba RC, Rzeszotarski WJ, et al. External imaging of cerebral muscarinic acetylcholine receptors. Science 1984; 223: 291-293.
4. 123IQNB and single photon emission computed tomography. Arch Neurol 1991; 48: 169-176.
5. McPherson DW, Lambert CR, Jahn K, et al. Resolution, in vitro and initial in vivo evaluation of isomers of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate. A high-affinity ligand for the muscarinic receptor. J Med Chem 1995; 38: 3908-3917.
6. McPherson DW, Knapp FF Jr. (1996) Structure elucidation via stereoselective synthesis of the acetate center of 1-azabicyclo[2.2.2]oct-3-yl α-hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate (IQNP). A high affinity muscarinic imaging agent for SPECT. J Org Chem 1996; 61: 8335-8337.
7. 123I-labelled E-(R,R)-IQNP: potential radioligands for visualization of M1 muscarinic acetylcholine receptors in brain. Nucl Med Biol 1998; 25: 209-214.
8. 76Br]BrQNP. Eur J Nucl Med 1997; 24: 475-482.
9. 11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology 1993; 113: 149-156.
10. Ehlert FJ, Roeske WR, Yamamura HI. Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. Life Sci 1994, 55: 2135-2145.
11. 125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB. Receptors and Signal Transduction 1997; 7: 45-54.